Optimizing Platelet Inhibition in Clopidogrel Poor Metabolizers Therapeutic Options and Practical Considerations

被引:21
作者
Angiolillo, Dominick J. [1 ]
Ueno, Masafumi [1 ]
机构
[1] Univ Florida, Coll Med Jacksonville, Dept Med, Div Cardiol, Jacksonville, FL 32209 USA
关键词
antiplatelet therapy; genetics; platelet reactivity; MAINTENANCE-DOSE CLOPIDOGREL; CORONARY-ARTERY-DISEASE; ADJUNCTIVE CILOSTAZOL; ANTIPLATELET THERAPY; DIABETES-MELLITUS; CYP2C19; GENOTYPE; VARIABILITY; REACTIVITY; PRASUGREL; CONSENSUS;
D O I
10.1016/j.jcin.2011.03.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:411 / 414
页数:4
相关论文
共 25 条
[1]   Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel The Importance of CYP2C19*2 Genotyping [J].
Alexopoulos, Dimitrios ;
Dimitropoulos, Gerasimos ;
Davlouros, Periklis ;
Xanthopoulou, Ioanna ;
Kassimis, George ;
Stavrou, Eleana F. ;
Hahalis, George ;
Athanassiadou, Aglaia .
JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (04) :403-410
[2]  
ANGIOLILLO DJ, 2011, J AM COLL C IN PRESS
[3]   A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study [J].
Angiolillo, Dominick J. ;
Capranzano, Piera ;
Goto, Shinya ;
Aslam, Mohammed ;
Desai, Bhaloo ;
Charlton, Ronald K. ;
Suzuki, Yoshie ;
Box, Lyndon C. ;
Shoemaker, Steven B. ;
Zenni, Martin M. ;
Guzman, Luis A. ;
Bass, Theodore A. .
EUROPEAN HEART JOURNAL, 2008, 29 (18) :2202-2211
[4]   Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study [J].
Angiolillo, Dominick J. ;
Shoemaker, Steven B. ;
Desai, Bhaloo ;
Yuan, Hang ;
Charlton, Ronald K. ;
Bernardo, Esther ;
Zenni, Martin M. ;
Guzman, Luis A. ;
Bass, Theodore A. ;
Costa, Marco A. .
CIRCULATION, 2007, 115 (06) :708-716
[5]   Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives [J].
Angiolillo, Dominick J. ;
Fernandez-Ortiz, Antonio ;
Bernardo, Esther ;
Alfonso, Fernando ;
Macaya, Carlos ;
Bass, Theodore A. ;
Costa, Marco A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) :1505-1516
[6]   Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study [J].
Angiolillo, Dominick J. ;
Saucedo, Jorge F. ;
DeRaad, Roger ;
Frelinger, Andrew L. ;
Gurbel, Paul A. ;
Costigan, Timothy M. ;
Jakubowski, Joseph A. ;
Ojeh, Clement K. ;
Effron, Mark B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) :1017-1023
[7]   No Role for Triple Antiplatelet Therapy? [J].
Antoniucci, David .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (03) :290-291
[8]   Pilot Study of the Antiplatelet Effect of Increased Clopidogrel Maintenance Dosing and Its Relationship to CYP2C19 Genotype in Patients With High On-Treatment Reactivity [J].
Barker, Colin M. ;
Murray, Sarah S. ;
Teirstein, Paul S. ;
Kandzari, David E. ;
Topol, Eric J. ;
Price, Matthew J. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (10) :1001-1007
[9]   Clopidogrel-Drug Interactions [J].
Bates, Eric R. ;
Lau, Wei C. ;
Angiolillo, Dominick J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (11) :1251-1263
[10]   Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate [J].
Bonello, Laurent ;
Tantry, Udaya S. ;
Marcucci, Rossella ;
Blindt, Ruediger ;
Angiolillo, Dominick J. ;
Becker, Richard ;
Bhatt, Deepak L. ;
Cattaneo, Marco ;
Collet, Jean Philippe ;
Cuisset, Thomas ;
Gachet, Christian ;
Montalescot, Gilles ;
Jennings, Lisa K. ;
Kereiakes, Dean ;
Sibbing, Dirk ;
Trenk, Dietmar ;
Van Werkum, Jochem W. ;
Paganelli, Franck ;
Price, Matthew J. ;
Waksman, Ron ;
Gurbel, Paul A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (12) :919-933